ALXO — ALX Oncology Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for ALX Oncology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	434	364	266	183	128
Net Total Accounts Receivable
Net Total Receivables	0	—	1	1	1.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets	436	367	271	189	134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.052	3.4	9.79	10.8	9.63
Long Term Investments
Other Long Term Assets
Total Assets	436	380	306	243	148
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.2	15.3	28.3	36	18.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.21	17.1	43	52.8	34.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	430	363	263	190	114
Total Liabilities & Shareholders' Equity	436	380	306	243	148
Total Common Shares Outstanding